| |
Number of Patients (N = 45) |
| Predicted Site of Origin |
Tissue of Origin Test |
Veridex 10-Gene Assay* |
| Lung, non-small cell |
11 |
10 |
| Pancreas |
6 |
7 |
| Sarcoma |
6 |
- |
| Ovary |
5 |
3 |
| Colon |
4 |
4 |
| Kidney |
3 |
- |
| Liver |
3 |
- |
| Breast |
2 |
0 |
| Stomach |
2 |
- |
| Bladder |
1 |
- |
| Prostate |
0 |
0 |
| Other |
0 |
19 |
| Unsuccessful |
0 |
2 |
| Non-diagnostic |
2 |
0 |
*The Veridex 10-gene assay allows detection of 6 sites of origin (lung, pancreas,
ovary, colon, breast, prostate). Cancers with gene signatures not matching any of
the 6 included types were categorized as “other.” |
